Analyst Targets Wedbush (Dan Ives): Outperform, $600 target Cantor Fitzgerald: Overweight, $485 target StoneX: Buy, $475 target JPMorgan: Neutral, $415…
This tiny piece of glass could be bigger than GPUs
A note from our friends at Brownstone Research(ad) Hi, Take a look at this… It’s smaller than a fingertip… It’s…
Health Insurance Premiums Are Up 58%. Next Comes 2027.
Open enrollment starts November 1, with subsidies gone and carriers exiting. Here is what households and investors should do now.
Nike’s China Slump Drives a Full-Year Guidance Reset
Analyst Targets Bank of America Securities – Downgrade to Underperform, target cut to $30 (from $47) Evercore ISI – In…
Telehealth’s Next Cliff Is 91 Days Away. The Margin Math Is Brutal.
Medicare waivers run through 2027. DEA flexibilities end Dec. 31, 2026. A final rule is expected this fall.
Official: This Irish Law Grants Citizenship by Mail
October 2, 2026 Bonus Content: Tesla’s Q3 Delivery Count Lands Today. What It Means A note from our friends at…
McKesson Just Locked In Six More Years With CVS Health
The extension removes the biggest renewal risk hanging over McKesson's $44.20–$45.00 earnings guidance.
Unsexy Trade System: 838/879 Winners
A note from our friends at Base Camp Trading(ad) Hey Trader, I have a huge problem. I’ve developed a “genius”…
BMW Is Cutting Managers. That Does Not Fix China.
What must change before any European automaker belongs in a one-stock portfolio.
Micron’s $54 Billion Quarter Has a $50 Billion Spending Problem
Micron Technology delivered the kind of earnings report that gets framed on a wall. Then the stock fell. Sponsored Your…